5 oncology research hubs adopting bioprinted tumor models in 2026
In the first quarter of 2026, major cancer institutes in the United States have officially integrated three-dimensional bioprinted tumor models into their drug discovery pipelines. These "organoids-on-a-chip" provide a high-fidelity representation of the human tumor microenvironment, allowing researchers to observe how malignant cells interact with surrounding healthy tissue and the immune...
0 Comments 0 Shares 234 Views 0 Reviews